Cargando…

Late gadolinium enhancement for re‐worsening left ventricular ejection fraction in patients with dilated cardiomyopathy

AIMS: This study aimed to evaluate the clinical parameters including late gadolinium enhancement (LGE) of cardiovascular magnetic resonance to predict re‐worsening of left ventricular ejection fraction (LVEF) in patients with dilated cardiomyopathy (DCM). METHODS AND RESULTS: We included 138 patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nabeta, Takeru, Ishii, Shunsuke, Ikeda, Yuki, Maemura, Kenji, Oki, Takumi, Yazaki, Mayu, Fujita, Teppei, Naruke, Takashi, Inomata, Takayuki, Ako, Junya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835548/ https://www.ncbi.nlm.nih.gov/pubmed/33270357 http://dx.doi.org/10.1002/ehf2.13133

Ejemplares similares

Clinical significance of left atrial geometry in dilated cardiomyopathy patients: A cardiovascular magnetic resonance study
por: Yazaki, Mayu, et al.
Publicado: (2020)

Native T1 high region and left ventricular ejection fraction recovery in patients with dilated cardiomyopathy
por: Yazaki, Mayu, et al.
Publicado: (2023)

Clinical Considerations When Introducing Sodium-Glucose Co-Transporter 2 Inhibition in Patients With Heart Failure
por: Yazaki, Mayu, et al.
Publicado: (2019)

An Irreversible Worsening Cardiac Function after Withdrawing Medical Treatments in a Patient with Dilated Cardiomyopathy: A Pathological Analysis
por: Yazaki, Mayu, et al.
Publicado: (2020)

Clinical valuables related to resolution of complete or advanced atrioventricular block after steroid therapy in patients with cardiac sarcoidosis
por: Nabeta, Takeru, et al.
Publicado: (2021)

Association between intestinal oedema and oral loop diuretic resistance in hospitalized patients with acute heart failure
por: Ikeda, Yuki, et al.
Publicado: (2021)

Response to letter to the editor entitled “Association between left atrial sphericity index and clinical outcomes in patients with systolic heart failure”
por: Yazaki, Mayu, et al.
Publicado: (2021)

Baseline cardiac magnetic resonance imaging versus baseline endomyocardial biopsy for the prediction of left ventricular reverse remodeling and prognosis in response to therapy in patients with idiopathic dilated cardiomyopathy
por: Nabeta, Takeru, et al.
Publicado: (2013)

Variation in heart rate range by 24‐h Holter monitoring predicts heart failure in patients with atrial fibrillation
por: Oikawa, Jun, et al.
Publicado: (2022)

Plasma Concentration and Pharmacodynamics of Edoxaban in Patients with Nonvalvular Atrial Fibrillation and Acute Heart Failure
por: Nabeta, Takeru, et al.
Publicado: (2021)

Results of Late Gadolinium Enhancement in Children Affected by Dilated Cardiomyopathy
por: Muscogiuri, Giuseppe, et al.
Publicado: (2017)

Late gadolinium enhancement cardiovascular magnetic resonance predicts clinical worsening in patients with pulmonary hypertension
por: Freed, Benjamin H, et al.
Publicado: (2012)

Population pharmacokinetics and optimization of the dosing regimen of digoxin in adult patients
por: Komatsu, Toshiaki, et al.
Publicado: (2015)

Tako-tsubo-like left ventricular dysfunction in a patient with COVID-19 demonstrated by non-invasive multi-modality imaging
por: Fujiyoshi, Kazuhiro, et al.
Publicado: (2020)

Prognostic value of myocardial strain and late gadolinium enhancement on cardiovascular magnetic resonance imaging in patients with idiopathic dilated cardiomyopathy with moderate to severely reduced ejection fraction
por: Pi, Seung-Hoon, et al.
Publicado: (2018)

Predictive Factors for Decreasing Left Ventricular Ejection Fraction and Progression to the Dilated Phase of Hypertrophic Cardiomyopathy
por: Ishihara, Kakeru, et al.
Publicado: (2023)

Prognostic impact of blood pressure response plus gadolinium enhancement in dilated cardiomyopathy
por: Tateishi, Emi, et al.
Publicado: (2015)

Intra-cardiac distribution of late gadolinium enhancement in cardiac sarcoidosis and dilated cardiomyopathy
por: Sano, Makoto, et al.
Publicado: (2016)

Outcome in Dilated Cardiomyopathy Related to the Extent, Location, and Pattern of Late Gadolinium Enhancement
por: Halliday, Brian P., et al.
Publicado: (2019)

Population pharmacokinetic analysis and dosing regimen optimization of penicillin G in patients with infective endocarditis
por: Komatsu, Toshiaki, et al.
Publicado: (2016)

Predictors and Mortality for Worsening Left Ventricular Ejection Fraction in Patients With HFpEF
por: Chen, Liling, et al.
Publicado: (2022)

Worsening effect of testosterone deficiency on males with heart failure with preserved ejection fraction
por: Hamam, Ahmed, et al.
Publicado: (2022)

New Challenges in Heart Failure with Reduced Ejection Fraction: Managing Worsening Events
por: Lavalle, Carlo, et al.
Publicado: (2023)

RE: Relation of Late Gadolinium Enhancement to Increased Ventricular Wall Stress in Dilated Cardiomyopathy
por: Alter, Peter
Publicado: (2016)

Electrocardiographic characteristics associated with late gadolinium enhancement and prognostic value in patients with dilated cardiomyopathy
por: Chayanopparat, Punyanuch, et al.
Publicado: (2023)

Association between late gadolinium enhancement and outcome in dilated cardiomyopathy: A meta-analysis
por: Feng, Xin-Yi, et al.
Publicado: (2023)

Ischemic and non-ischemic patterns of late gadolinium enhancement in heart failure with reduced ejection fraction
por: Matusik, Patrycja S., et al.
Publicado: (2021)

Outcomes of Spironolactone Withdrawal in Dilated Cardiomyopathy With Improved Ejection Fraction
por: Chen, Yanjia, et al.
Publicado: (2021)

Effects of Hypertrophic and Dilated Cardiac Geometric Remodeling on Ejection Fraction
por: Zheng, Yu, et al.
Publicado: (2022)

Immunoadsorption Therapy for Patients with Dilated Cardiomyopathy and Heart Failure
por: Ikeda, Uichi, et al.
Publicado: (2008)

Prognostic value of late gadolinium enhancement in cardiac MRI of non-ischemic dilated cardiomyopathy patients
por: Behera, Dibya Ranjan, et al.
Publicado: (2020)

Combination of late gadolinium enhancement and genotype improves prediction of prognosis in non‐ischaemic dilated cardiomyopathy
por: Mirelis, Jesús G., et al.
Publicado: (2022)

A case of pregnancy complicated with dilated cardiomyopathy 1X
por: Oki, Shinya, et al.
Publicado: (2015)

Late-gadolinium enhancement is common in older pediatric heart transplant recipients and is associated with lower ejection fraction
por: Lawson, Andrew A., et al.
Publicado: (2023)

Plasma microrna expression profile for reduced ejection fraction in dilated cardiomyopathy
por: Calderon-Dominguez, Maria, et al.
Publicado: (2021)

Description of A/C gene mutation related dilated cardiomyopathy with gadolinium- enhanced magnetic resonance imaging
por: Holmström, Miia, et al.
Publicado: (2011)

Bio-imaging: late gadolinium enhancement in dilated cardiomyopathy and its relation to novel biomarkers of fibrosis and remodeling
por: Abdel-Aty, Hassan, et al.
Publicado: (2013)

Comparison of Ventricular Inducibility with Late Gadolinium Enhancement and Myocardial Inflammation in Endomyocardial Biopsy in Patients with Dilated Cardiomyopathy
por: Mueller, Karin A. L., et al.
Publicado: (2016)

The Role of Circulating Collagen Turnover Biomarkers and Late Gadolinium Enhancement in Patients with Non-Ischemic Dilated Cardiomyopathy
por: Revnic, Radu, et al.
Publicado: (2022)

Optimization of Patient Pathway in Heart Failure with Reduced Ejection Fraction and Worsening Heart Failure. Role of Vericiguat
por: González-Juanatey, José Ramón, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_un23aguidsckkqcp1fkn7ku7tm